ArticleCureus2025
The Hidden Shunt: An Asymptomatic Atrial Septal Defect Revealed by Echocardiography in a High-Performance Teenage Football Player.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pre-participation cardiovascular evaluation aims to detect occult cardiac conditions that may increase the risk of sudden cardiac events in young athletes. Although echocardiography is not universally recommended for systematic screening, it can reveal silent congenital anomalies, particularly in highly trained individuals. In this report, we describe a case of a 14-year-old competitive football player with no prior medical history who underwent routine pre-participation evaluation. Clinical examination and resting electrocardiogram were normal. Transthoracic echocardiography (TTE), however, revealed an ostium secundum atrial septal defect (ASD) with mildly enlarged right chambers and a Qp/Qs ratio of 1.7, in the absence of pulmonary hypertension. Transesophageal echocardiography (TEE) confirmed adequate rims for device closure. Percutaneous occlusion using an ASD device was successfully performed without complications. Follow-up at one and three months confirmed appropriate device positioning and regression of right-heart dilation. This case highlights the potential role of echocardiography in uncovering silent congenital heart disease (CHD) in young athletes. Although routine TTE screening is not recommended for the general athletic population, selected high-level athletes may benefit from imaging to detect structural anomalies not identifiable clinically. The literature supports early identification and percutaneous treatment of significant ASDs to prevent long-term right-heart remodeling and adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.